发布求助
文献互助 智能选刊 最新文献

British Journal of Haematology最新文献

筛选
英文 中文
Precision immune-guided management of cytomegalovirus (CMV) after allogeneic haematopoietic stem cell transplantation in the letermovir era: A pragmatic framework. letermovil时代同种异体造血干细胞移植后巨细胞病毒（CMV）的精确免疫引导管理：一个实用框架。
IF 3.8 2区 医学
British Journal of Haematology Pub Date : 2026-04-01 Epub Date: 2026-01-14 DOI: 10.1111/bjh.70327
Xinyi Jiang, Ziwei Xu, Huafang Wang
{"title":"Precision immune-guided management of cytomegalovirus (CMV) after allogeneic haematopoietic stem cell transplantation in the letermovir era: A pragmatic framework.","authors":"Xinyi Jiang, Ziwei Xu, Huafang Wang","doi":"10.1111/bjh.70327","DOIUrl":"10.1111/bjh.70327","url":null,"abstract":"","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":"1482-1485"},"PeriodicalIF":3.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145970349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transplant outcomes in adolescents and young adults with Philadelphia-positive B-cell acute lymphoblastic leukaemia. 费城阳性b细胞急性淋巴细胞白血病的青少年和年轻人的移植结果。
IF 3.8 2区 医学
British Journal of Haematology Pub Date : 2026-04-01 Epub Date: 2026-01-25 DOI: 10.1111/bjh.70347
Manar Aleid, Riad El Fakih, Amr Hanbali, Feras Alfraih, Haya Alothaimeen, Tusneem Elhassan, Ali Alahmari, Walid Rasheed, Fahad Almohareb, Naeem Chaudhri, Shaykhah Alotaibi, Fahad Alsharif, Marwan Shaheen, Saud Alhayli, Hanan Alkhaldi, Ruah Alyamany, Alfadel Alshaibani, Ahmad S Alotaibi, Abdullah Alamer, Abdulwahab A Albabtain, Syed Osman Ahmed, Hazzaa Alzahrani, Mahmoud Aljurf, Ayman Saad, Mansour Alfayez
{"title":"Transplant outcomes in adolescents and young adults with Philadelphia-positive B-cell acute lymphoblastic leukaemia.","authors":"Manar Aleid, Riad El Fakih, Amr Hanbali, Feras Alfraih, Haya Alothaimeen, Tusneem Elhassan, Ali Alahmari, Walid Rasheed, Fahad Almohareb, Naeem Chaudhri, Shaykhah Alotaibi, Fahad Alsharif, Marwan Shaheen, Saud Alhayli, Hanan Alkhaldi, Ruah Alyamany, Alfadel Alshaibani, Ahmad S Alotaibi, Abdullah Alamer, Abdulwahab A Albabtain, Syed Osman Ahmed, Hazzaa Alzahrani, Mahmoud Aljurf, Ayman Saad, Mansour Alfayez","doi":"10.1111/bjh.70347","DOIUrl":"10.1111/bjh.70347","url":null,"abstract":"","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":"1467-1471"},"PeriodicalIF":3.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146045752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zanubrutinib, lenalidomide, rituximab, temozolomide ± methotrexate as first-line treatment for primary central nervous system lymphoma: A prospective, open-label, multicentre clinical trial. 扎努布替尼、来那度胺、利妥昔单抗、替莫唑胺±甲氨喋呤作为原发性中枢神经系统淋巴瘤的一线治疗：一项前瞻性、开放标签、多中心临床试验
IF 3.8 2区 医学
British Journal of Haematology Pub Date : 2026-04-01 Epub Date: 2026-01-26 DOI: 10.1111/bjh.70335
Jia Song, Huijuan Jiang, Kai Ding, Hui Liu, Yihao Wang, Shan Gao, Yue Ren, Zhaoyun Liu, Jie Zhuo, Bing Li, Guokai Wang, Zongjiu Jiao, Da Gao, Rong Fu
{"title":"Zanubrutinib, lenalidomide, rituximab, temozolomide ± methotrexate as first-line treatment for primary central nervous system lymphoma: A prospective, open-label, multicentre clinical trial.","authors":"Jia Song, Huijuan Jiang, Kai Ding, Hui Liu, Yihao Wang, Shan Gao, Yue Ren, Zhaoyun Liu, Jie Zhuo, Bing Li, Guokai Wang, Zongjiu Jiao, Da Gao, Rong Fu","doi":"10.1111/bjh.70335","DOIUrl":"10.1111/bjh.70335","url":null,"abstract":"<p><p>In this prospective, multicentre clinical trial, we evaluated zanubrutinib combined with lenalidomide, temozolomide and rituximab monoclonal antibody ± methotrexate (RLZT ± MTX) as first-line treatment for primary central nervous system lymphoma. RLZT ± MTX demonstrated good efficacy and safety, especially for elderly patients who cannot undergo intensive chemotherapy.</p>","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":"1424-1428"},"PeriodicalIF":3.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146045799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-centre analysis of prophylactic dexamethasone on the incidence and severity of cytokine release syndrome and immune effector cell-associated neurotoxicity in patients receiving axicabtagene ciloleucel. 预防性地塞米松对接受阿西卡布基西洛尔治疗患者细胞因子释放综合征和免疫效应细胞相关神经毒性的发生率和严重程度的单中心分析。
IF 3.8 2区 医学
British Journal of Haematology Pub Date : 2026-04-01 Epub Date: 2026-01-19 DOI: 10.1111/bjh.70343
Daniel P Schrum, Erin Eberwein, Sikai Cheng, Amber Feng, Erin Kennedy, Taewoong Choi, Jonathan Huggins, Yubin Kang, Suzanne Kirby, Matthew McKinney, Sendhilnathan Ramalingam, Alexandra Stefanovic, Jie Wang, Mitchell E Horwitz, Chenyu Lin
{"title":"Single-centre analysis of prophylactic dexamethasone on the incidence and severity of cytokine release syndrome and immune effector cell-associated neurotoxicity in patients receiving axicabtagene ciloleucel.","authors":"Daniel P Schrum, Erin Eberwein, Sikai Cheng, Amber Feng, Erin Kennedy, Taewoong Choi, Jonathan Huggins, Yubin Kang, Suzanne Kirby, Matthew McKinney, Sendhilnathan Ramalingam, Alexandra Stefanovic, Jie Wang, Mitchell E Horwitz, Chenyu Lin","doi":"10.1111/bjh.70343","DOIUrl":"10.1111/bjh.70343","url":null,"abstract":"","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":"1458-1461"},"PeriodicalIF":3.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146002675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dose de-escalation of alemtuzumab in matched unrelated donor haematopoietic stem cell transplantation. 阿仑单抗在匹配非亲属供体造血干细胞移植中的剂量递减。
IF 3.8 2区 医学
British Journal of Haematology Pub Date : 2026-04-01 Epub Date: 2026-01-08 DOI: 10.1111/bjh.70318
Maymoon M Madkhali, Alex Mitchell, Callum Wright, Kim Pearce, Srishty Aku, Sarah Pagan, Louise Duncan, Jason Lam, Jamie Macdonald, Paul Milne, Amy Publicover, Erin Hurst, Venetia Bigley, Geoffrey Hale, Matthew Collin
{"title":"Dose de-escalation of alemtuzumab in matched unrelated donor haematopoietic stem cell transplantation.","authors":"Maymoon M Madkhali, Alex Mitchell, Callum Wright, Kim Pearce, Srishty Aku, Sarah Pagan, Louise Duncan, Jason Lam, Jamie Macdonald, Paul Milne, Amy Publicover, Erin Hurst, Venetia Bigley, Geoffrey Hale, Matthew Collin","doi":"10.1111/bjh.70318","DOIUrl":"10.1111/bjh.70318","url":null,"abstract":"<p><p>Alemtuzumab in vivo T-cell depletion is safe and effective at a single dose of 30 mg in reduced-intensity matched unrelated donor transplants.</p>","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":"1477-1481"},"PeriodicalIF":3.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145931613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia. 低剂量PTCy和低剂量ATG可改善急性髓系白血病匹配非亲属供体异体移植的早期移植效果。
IF 3.8 2区 医学
British Journal of Haematology Pub Date : 2026-04-01 Epub Date: 2026-02-26 DOI: 10.1111/bjh.70380
Nihar Desai, Mohammed Althobaiti, Carol Chen, Eshrak Al-Shaibani, Tommy Alfaro Moya, Igor Novitzky-Basso, Ivan Pasic, Fotios V Michelis, Dennis D Kim, Rajat Kumar, Jonas Mattsson, Arjun D Law, Auro Viswabandya
{"title":"Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia.","authors":"Nihar Desai, Mohammed Althobaiti, Carol Chen, Eshrak Al-Shaibani, Tommy Alfaro Moya, Igor Novitzky-Basso, Ivan Pasic, Fotios V Michelis, Dennis D Kim, Rajat Kumar, Jonas Mattsson, Arjun D Law, Auro Viswabandya","doi":"10.1111/bjh.70380","DOIUrl":"10.1111/bjh.70380","url":null,"abstract":"<p><p>Post-transplant cyclophosphamide (PTCy) is associated with infectious and organ toxicities. Dose optimization may reduce these risks while maintaining efficacy. We initiated a prospective pilot study in July 2024 evaluating reduced-dose PTCy (35 mg/kg on days +3 and +4; PTCy70) with low-dose anti-thymocyte globulin (ATG) (2 mg/kg) in adults with acute myeloid leukaemia (AML) undergoing matched unrelated donor (MUD) transplantation. Outcomes were compared with a contemporary cohort receiving PTCy100 with ATG 2 mg/kg. Of 173 patients, 41 received PTCy70. Platelet engraftment was faster with PTCy70, 13 vs. 16 days (p < 0.001). In multivariable analysis, PTCy70 was associated with lower risk of bloodstream infections (hazard ratio [HR] 0.39, 95% confidence interval [CI], 0.19-0.78, p = 0.007). At day+100, the incidence of grade II-IV (30.4% vs. 20.3%, p = 0.17), grade III-IV acute graft-versus-host disease (GVHD) (3% vs. 3%, p = 0.08) and non-relapse mortality (3.8% vs. 2.8%, p = 0.67) were similar between groups. Cardiac events were less frequent with PTCy70 (5% vs. 17%; p = 0.06). No cases of sinusoidal obstruction syndrome were observed in the PTCy70 group. At 12 months, relapse (11.1% vs. 15.3%, p = 0.88) and overall survival (79.6% vs. 83.2%, p = 0.87) did not differ between groups. PTCy70 was associated with faster platelet engraftment, fewer bloodstream infections and cardiac events without compromising GVHD, relapse or survival, supporting evaluation in randomized trials.</p>","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":"1359-1368"},"PeriodicalIF":3.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147300343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expanding genetic landscape of inherited bone marrow failure syndromes: Insights from the Canadian Inherited Marrow Failure Registry (CIMFR) (2001-2023). 扩大遗传性骨髓衰竭综合征的遗传景观：来自加拿大遗传性骨髓衰竭登记（CIMFR）（2001-2023）的见解。
IF 3.8 2区 医学
British Journal of Haematology Pub Date : 2026-04-01 Epub Date: 2026-03-17 DOI: 10.1111/bjh.70387
Ye Jee Shim, Jae Hee Lee, Talya Wittmann Dayagi, Robert J Klaassen, Yves D Pastore, Sharon Abish, MacGregor Steele, Catherine Corriveau-Bourque, Vicky R Breakey, Roona Sinha, Soumitra Tole, Lisa Goodyear, Josee Brossard, Stephanie Villeneuve, Bruce Crooks, Meera Rayar, Laura Wheaton, Sara Ogle, Michaela Cada, Hongbing Li, Rinu Mathew, Yigal Dror
{"title":"Expanding genetic landscape of inherited bone marrow failure syndromes: Insights from the Canadian Inherited Marrow Failure Registry (CIMFR) (2001-2023).","authors":"Ye Jee Shim, Jae Hee Lee, Talya Wittmann Dayagi, Robert J Klaassen, Yves D Pastore, Sharon Abish, MacGregor Steele, Catherine Corriveau-Bourque, Vicky R Breakey, Roona Sinha, Soumitra Tole, Lisa Goodyear, Josee Brossard, Stephanie Villeneuve, Bruce Crooks, Meera Rayar, Laura Wheaton, Sara Ogle, Michaela Cada, Hongbing Li, Rinu Mathew, Yigal Dror","doi":"10.1111/bjh.70387","DOIUrl":"10.1111/bjh.70387","url":null,"abstract":"<p><p>Inherited bone marrow failure syndromes (IBMFSs) are genetically heterogeneous with an expanding spectrum of causative genes. Recent molecular advances are thought to have contributed to genetic identification, yet the true gain in diagnostic yield remains unclear. Accordingly, this study aims to investigate the evolving genetic landscape of IBMFSs using data from the Canadian Inherited Marrow Failure Registry by analysing patients enrolled from the 2001-2010 cohort to the 2011-2023 cohort. Among 407 genetically tested patients, 308 (75.7%) underwent molecular diagnosis, with variants identified in 62 distinct genes. These genes encompass diverse cellular pathways, including DNA repair, telomere maintenance, transcription, RNA splicing, ribosome biogenesis, nuclear envelope, Golgi, endoplasmic reticulum and mitochondrial integrity, cell signalling, cytokine receptor activity and cytoskeletal regulation. A total of 453 variants were identified, including pathogenic copy number variants in 12.7% (39/308) of cases, representing 10.4% (47/453) of all variants. Diagnostic yield increased from 51.6% in 2001-2010 to 75.7% in 2001-2023, and genetic testing enabled classification of 17.5% (54/308) of previously unclassified cases. These findings underscore the rapid growth of IBMFS genetic knowledge and the crucial value of comprehensive testing, although 24.3% of cases remain unresolved, likely due to novel syndromes and unrecognised IBMFS-related genes.</p>","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":"1407-1418"},"PeriodicalIF":3.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147471994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MEK inhibition alleviates macrophage overactivation without compromising the efficacy of CAR-T-cell therapy. MEK抑制减轻了巨噬细胞的过度激活，而不影响car - t细胞治疗的效果。
IF 3.8 2区 医学
British Journal of Haematology Pub Date : 2026-04-01 Epub Date: 2026-02-18 DOI: 10.1111/bjh.70364
Hui Li, Youming Wang, Yingxiang Wang, Li Ding, Sujun Li, Miaomiao Wu, Qianwen Xu, Yuanli Chen, Xingbing Wang
{"title":"MEK inhibition alleviates macrophage overactivation without compromising the efficacy of CAR-T-cell therapy.","authors":"Hui Li, Youming Wang, Yingxiang Wang, Li Ding, Sujun Li, Miaomiao Wu, Qianwen Xu, Yuanli Chen, Xingbing Wang","doi":"10.1111/bjh.70364","DOIUrl":"10.1111/bjh.70364","url":null,"abstract":"<p><p>This study presents mitogen-activated protein kinase kinase (MEK) inhibition as a strategy for cytokine release syndrome (CRS) and secondary haemophagocytic lymphohistiocytosis (sHLH) in chimeric antigen receptor (CAR)-T therapy, utilizing MEK's regulatory actions that target macrophage activation, cytokine secretion from both macrophages and CAR-T cells, supported by evidence of unimpaired CAR-T-cell therapeutic efficacy of alleviated CAR-T-related inflammation.</p>","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":"1448-1453"},"PeriodicalIF":3.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146217998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improvement in survival of patients with higher risk but not lower risk myelodysplastic syndromes over 20 years: A retrospective study from Nagasaki, Japan. 高风险而非低风险骨髓增生异常综合征患者20年生存率的改善：来自日本长崎的一项回顾性研究
IF 3.8 2区 医学
British Journal of Haematology Pub Date : 2026-04-01 Epub Date: 2026-01-25 DOI: 10.1111/bjh.70345
Takafumi Furumoto, Koji Ando, Eo Toriyama, Tomoko Hata, Hikaru Sakamoto, Masahiko Chiwata, Hideaki Kitanosono, Jun Nakashima, Takeharu Kato, Masataka Taguchi, Makiko Horai, Hidehiro Itonaga, Shinya Sato, Yasushi Sawayama, Daisuke Imanishi, Yoshitaka Imaizumi, Tatsuro Jo, Shinichiro Yoshida, Yukiyoshi Moriuchi, Yasushi Miyazaki
{"title":"Improvement in survival of patients with higher risk but not lower risk myelodysplastic syndromes over 20 years: A retrospective study from Nagasaki, Japan.","authors":"Takafumi Furumoto, Koji Ando, Eo Toriyama, Tomoko Hata, Hikaru Sakamoto, Masahiko Chiwata, Hideaki Kitanosono, Jun Nakashima, Takeharu Kato, Masataka Taguchi, Makiko Horai, Hidehiro Itonaga, Shinya Sato, Yasushi Sawayama, Daisuke Imanishi, Yoshitaka Imaizumi, Tatsuro Jo, Shinichiro Yoshida, Yukiyoshi Moriuchi, Yasushi Miyazaki","doi":"10.1111/bjh.70345","DOIUrl":"10.1111/bjh.70345","url":null,"abstract":"","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":"1443-1447"},"PeriodicalIF":3.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13071489/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146045708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuum of care after newborn screening for sickle cell disease: Multinational evidence from a systematic review and meta-analysis. 新生儿镰状细胞病筛查后的连续护理：来自系统评价和荟萃分析的多国证据
IF 3.8 2区 医学
British Journal of Haematology Pub Date : 2026-04-01 Epub Date: 2026-01-13 DOI: 10.1111/bjh.70319
Tanveer Rehman, Srijeeta Mitra, Kalpita Ganpat Gawit, Ravindra Kumar, Sritama Dutta, Ananya Anurakta Pattanaik, Lakhan Majhee, Tanu Anand, Manisha Madkaikar, Sanghamitra Pati
{"title":"Continuum of care after newborn screening for sickle cell disease: Multinational evidence from a systematic review and meta-analysis.","authors":"Tanveer Rehman, Srijeeta Mitra, Kalpita Ganpat Gawit, Ravindra Kumar, Sritama Dutta, Ananya Anurakta Pattanaik, Lakhan Majhee, Tanu Anand, Manisha Madkaikar, Sanghamitra Pati","doi":"10.1111/bjh.70319","DOIUrl":"10.1111/bjh.70319","url":null,"abstract":"","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":"1486-1491"},"PeriodicalIF":3.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13071484/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145964864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书